Intratracheal Epinephrine for Bronchospasm: Dosing Recommendations
Intratracheal epinephrine is NOT the recommended route for treating bronchospasm—inhaled beta-agonists (nebulized albuterol) are first-line therapy, with intramuscular epinephrine reserved for anaphylaxis-associated bronchospasm. However, when intratracheal administration is necessary during cardiac arrest or in intubated patients with refractory bronchospasm, specific dosing applies.
Primary Treatment Algorithm for Bronchospasm
First-Line Therapy
- Nebulized albuterol: 2.5-5 mg in 3 mL saline, repeat as necessary 1
- This is the standard approach for bronchospasm resistant to adequate doses of epinephrine in anaphylaxis
When Intramuscular Epinephrine is Indicated
For bronchospasm associated with anaphylaxis:
- Adults and children ≥4 years: 0.01 mg/kg of 1:1000 solution IM (maximum 0.3-0.5 mg)
- Repeat every 5-20 minutes as needed 2
- IM route in the lateral thigh is preferred over subcutaneous
Intratracheal (Endotracheal) Epinephrine Dosing
During Cardiopulmonary Resuscitation
When IV/IO access is unavailable:
Infants and Children:
- 0.1 mg/kg of 1:1000 solution (0.1 mL/kg) 2, 3
- Maximum dose: 2.5 mg 3
- This is 10 times the IV dose of 0.01 mg/kg
Neonates:
- 0.05-0.1 mg/kg via endotracheal tube 4
- Higher dose needed compared to IV route (0.01-0.03 mg/kg IV)
- Follow with saline flush (1-5 mL based on patient size)
For Refractory Post-Intubation Bronchospasm
Based on case evidence when standard therapies fail:
- 0.5 mg of 1:10,000 epinephrine diluted in 10 mL normal saline administered via endotracheal tube 5
- This represents an off-label, last-resort intervention for severe, refractory bronchospasm in intubated patients
Critical Dosing Principles
Why Higher Doses Are Required for Endotracheal Route
- Bioavailability is significantly lower via endotracheal route compared to IV/IO 4, 6
- Peak plasma concentrations occur at 5 minutes (vs. 1 minute for IV) 4
- Standard IV doses given endotracheally can cause paradoxical hypotension due to unopposed beta-2 vasodilation 6
- Research suggests 10-fold the IV dose (0.1 mg/kg vs 0.01 mg/kg) is needed to achieve therapeutic effect 6
Administration Technique
- Dilute in isotonic saline (1-5 mL based on patient size) 2, 3
- Follow with 5 mL normal saline flush and 5 positive-pressure ventilations 3
- Stop chest compressions briefly during administration if CPR is in progress 3
Important Caveats and Pitfalls
Route Selection Hierarchy
- IV/IO epinephrine is always preferred when vascular access is available 4
- Endotracheal route is a temporizing measure while establishing vascular access
- Most patients require subsequent IV doses to achieve return of spontaneous circulation 4
Bronchospasm-Specific Considerations
- Nebulized albuterol remains superior for isolated bronchospasm 1
- Intratracheal epinephrine for bronchospasm is primarily supported by case reports 7, 5, not high-quality trials
- The evidence base for epinephrine vs. selective beta-2 agonists in acute asthma shows similar efficacy but low quality evidence 8
Concentration Confusion Risk
- 1:1000 (1 mg/mL) for endotracheal route in arrest: 0.1 mL/kg 2, 3
- 1:10,000 (0.1 mg/mL) for IV route: 0.1 mL/kg (delivers 0.01 mg/kg) 2
- Verify concentration before administration to prevent 10-fold dosing errors
Monitoring Requirements
- Continuous pulse oximetry
- Cardiac monitoring for arrhythmias
- Blood pressure monitoring
- Be prepared for potential adverse effects including tachycardia, hypertension, and arrhythmias
When NOT to Use Endotracheal Route
- Never use for non-lipid-soluble drugs (sodium bicarbonate, calcium) 3
- Avoid as first-line when IV/IO access is readily achievable
- Not indicated for routine bronchospasm management outside of cardiac arrest or extreme refractory cases